Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Global risk classification and clinical SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) score in patients undergoing percutaneous or surgical left main revascularization.
Capodanno D, Caggegi A, Miano M, Cincotta G, Dipasqua F, Giacchi G, Capranzano P, Ussia G, Di Salvo ME, La Manna A, Tamburino C. Capodanno D, et al. Among authors: di salvo me. JACC Cardiovasc Interv. 2011 Mar;4(3):287-97. doi: 10.1016/j.jcin.2010.10.013. JACC Cardiovasc Interv. 2011. PMID: 21435606 Free article.
Comparison of drug-eluting stents and bare-metal stents for the treatment of unprotected left main coronary artery disease in acute coronary syndromes.
Tamburino C, Di Salvo ME, Capodanno D, Palmerini T, Sheiban I, Margheri M, Vecchi G, Sangiorgi G, Piovaccari G, Bartorelli A, Briguori C, Ardissino D, Di Pede F, Ramondo A, Inglese L, Petronio AS, Bolognese L, Benassi A, Palmieri C, Filippone V, De Servi S. Tamburino C, et al. Among authors: di pede f, di salvo me. Am J Cardiol. 2009 Jan 15;103(2):187-93. doi: 10.1016/j.amjcard.2008.08.059. Epub 2008 Oct 30. Am J Cardiol. 2009. PMID: 19121434
Real world safety and efficacy of the Janus Tacrolimus-Eluting stent: long-term clinical outcome and angiographic findings from the Tacrolimus-Eluting STent (TEST) registry.
Tamburino C, Di Salvo ME, Capodanno D, Capranzano P, Parisi R, Mirabella F, Scardaci F, Ussia G, Galassi AR, Fiscella D, Mehran R, Dangas G. Tamburino C, et al. Among authors: di salvo me. Catheter Cardiovasc Interv. 2009 Feb 1;73(2):243-8. doi: 10.1002/ccd.21750. Catheter Cardiovasc Interv. 2009. PMID: 19156896
Long-term clinical benefit of drug-eluting stents over bare-metal stents in diabetic patients with de novo left main coronary artery disease: results from a real-world multicenter registry.
Capodanno D, Di Salvo ME, Palmerini T, Sheiban I, Margheri M, Vecchi G, Sangiorgi G, Piovaccari G, Bartorelli A, Briguori C, Ardissino D, Di Pede F, Ramondo A, Inglese L, Petronio AS, Bolognese L, Benassi A, Palmieri C, Filippone V, De Servi S, Tamburino C. Capodanno D, et al. Among authors: di pede f, di salvo me. Catheter Cardiovasc Interv. 2009 Feb 15;73(3):310-6. doi: 10.1002/ccd.21845. Catheter Cardiovasc Interv. 2009. PMID: 19214964
Are drug-eluting stents superior to bare-metal stents in patients with unprotected non-bifurcational left main disease? Insights from a multicentre registry.
Tamburino C, Di Salvo ME, Capodanno D, Marzocchi A, Sheiban I, Margheri M, Maresta A, Barlocco F, Sangiorgi G, Piovaccari G, Bartorelli A, Briguori C, Ardissino D, Di Pede F, Ramondo A, Inglese L, Petronio AS, Bolognese L, Benassi A, Palmieri C, Patti A, De Servi S. Tamburino C, et al. Among authors: di pede f, di salvo me. Eur Heart J. 2009 May;30(10):1171-9. doi: 10.1093/eurheartj/ehp052. Epub 2009 Mar 10. Eur Heart J. 2009. PMID: 19276194
First-in-man 1-year clinical outcomes of the Catania Coronary Stent System with Nanothin Polyzene-F in de novo native coronary artery lesions: the ATLANTA (Assessment of The LAtest Non-Thrombogenic Angioplasty stent) trial.
Tamburino C, La Manna A, Di Salvo ME, Sacchetta G, Capodanno D, Mehran R, Dangas G, Corcos T, Prati F. Tamburino C, et al. Among authors: di salvo me. JACC Cardiovasc Interv. 2009 Mar;2(3):197-204. doi: 10.1016/j.jcin.2008.12.006. JACC Cardiovasc Interv. 2009. PMID: 19463426 Free article. Clinical Trial.
Optical coherence tomographic results at six-month follow-up evaluation of the CATANIA coronary stent system with nanothin Polyzene-F surface modification (from the Assessment of The LAtest Non-Thrombogenic Angioplasty Stent [ATLANTA] trial).
La Manna A, Capodanno D, Cera M, Di Salvo ME, Sacchetta G, Corcos T, Prati F, Tamburino C. La Manna A, et al. Among authors: di salvo me. Am J Cardiol. 2009 Jun 1;103(11):1551-5. doi: 10.1016/j.amjcard.2009.01.378. Epub 2009 Apr 8. Am J Cardiol. 2009. PMID: 19463514 Clinical Trial.
Usefulness of SYNTAX score to select patients with left main coronary artery disease to be treated with coronary artery bypass graft.
Capodanno D, Capranzano P, Di Salvo ME, Caggegi A, Tomasello D, Cincotta G, Miano M, Patané M, Tamburino C, Tolaro S, Patané L, Calafiore AM, Tamburino C. Capodanno D, et al. Among authors: di salvo me. JACC Cardiovasc Interv. 2009 Aug;2(8):731-8. doi: 10.1016/j.jcin.2009.06.003. JACC Cardiovasc Interv. 2009. PMID: 19695541 Free article.
44 results